(Q40528931)

21 September 2017

N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis (English)

1 reference

brain natriuretic peptide

21 September 2017

0 references

author name string

Per Hildebrandt

1

1 reference

21 September 2017

Mikael Boesen

2

1 reference

21 September 2017

Michael Olsen

3

1 reference

21 September 2017

Kristian Wachtell

4

1 reference

21 September 2017

Bjoern Groenning

5

1 reference

21 September 2017

1 March 2004

1 reference

European Journal of Heart Failure

21 September 2017

1 reference

21 September 2017

6

1 reference

21 September 2017

3

1 reference

21 September 2017

313-317

1 reference

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

NT-proANP and BNP in Renovascular and in Severe and Mild Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.001

10.1016/J.EJHEART.2004.01.001

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference